Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.
Roxana MehranDidier TchétchéAnna Sonia PetronioJulinda MehilliSamantha SartoriThierry LefèvrePatrizia PresbiteroPiera CapranzanoAlessandro IadanzaGennaro SardellaNicolas M Van MieghemSabato SorrentinoBimmer E P M ClaessenJaya ChandrasekharBirgit VogelDeborah N KalkmanEmanuele MeligaNicolas DumonteilChiara FraccaroDaniela TrabattoniGhada MikhailMaria-Cruz Ferrer-GraciaChristoph NaberPeter KievitUsman BaberSamin SharmaMarie-Claude MoriceAlaide ChieffoRoxana Mehrannull nullPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)
The presence of CAD in women undergoing TAVR, with or without recent PCI, was associated with long-term poorer outcomes.
Keyphrases
- transcatheter aortic valve replacement
- coronary artery disease
- percutaneous coronary intervention
- aortic stenosis
- aortic valve
- coronary artery bypass grafting
- polycystic ovary syndrome
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- transcatheter aortic valve implantation
- antiplatelet therapy
- cardiovascular events
- acute coronary syndrome
- pregnancy outcomes
- cervical cancer screening
- ejection fraction
- atrial fibrillation
- breast cancer risk
- coronary artery bypass
- pregnant women
- cardiovascular disease
- type diabetes
- metabolic syndrome
- adipose tissue
- left ventricular
- skeletal muscle
- weight loss